Ads
related to: SARS-CoV-2
Search results
New study reveals long-term mental health risks after COVID-19
Medical Xpress· 7 days agoA new study published in Nature Human Behaviour sheds light on the long-term mental health consequences of COVID-19 infection and the growing evidence of the protective effect of vaccination on reducing the risk.
UC San Francisco Scientists Find COVID-19 Virus Can Stay in the Body More Than a Year After...
Sierra Sun Times· 7 days agoThe scientists found pieces of SARS-CoV-2, referred to as COVID antigens, lingering in the blood up...
Invivyd's monoclonal antibody receives FDA emergency use authorization
Investing.com· 6 days agoInvivyd, Inc. ( NASDAQ :IVVD), a biopharmaceutical company, announced today the U.S. Food and Drug...
Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine
Digital Journal· 2 days ago(NASDAQ:MRNA) today announced that mRNA-1283, the Company's next-generation COVID-19 vaccine, has successfully met the primary endpoints of its Phase 3 clinical trial, demonstrating a higher ...
Side Does Matter: Unlocking the Secret Power of Vaccine Placement
SciTechDaily· 5 days agoResearch conducted during Germany’s COVID-19 vaccination effort shows that getting both vaccine...
Hologic, Inc. (NASDAQ:HOLX) Shares Sold by Artemis Investment Management LLP
ETF DAILY NEWS· 1 day agoArtemis Investment Management LLP lowered its position in shares of Hologic, Inc. (NASDAQ:HOLX – Free Report) by 42.8% during the fourth quarter, Holdings Channel reports. The firm owned 12,421 ...
How COVID-19 Treatments Affect Patients With IBD
Medscape· 2 days agoInflammatory bowel disease therapies for patients may need to be briefly halted during treatment for COVID-19, but it does not increase flares.
Viral Genetics Confirms What On-the-Ground Activists Knew Early in the Mpox Outbreak
Scientific American· 22 hours agoIn June 2022 I sat shaking my head as I heard from senior U.S. government officials that mpox (then...
Hologic, Inc. (NASDAQ:HOLX) Shares Sold by Whittier Trust Co.
ETF DAILY NEWS· 1 day agoWhittier Trust Co. decreased its position in Hologic, Inc. (NASDAQ:HOLX – Free Report) by 24.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities ...
Invivyd Announces Interim Exploratory Data on VYD222 from Ongoing CANOPY Clinical Trial - Invivyd...
Benzinga· 6 days agoAnalysis of secondary endpoint of symptomatic COVID-19 events in CANOPY is unrelated to regulatory filing or review, but may be hypothesis generating for future Invivyd discovery and development workToday's update on Day
Ads
related to: SARS-CoV-2